APO Research
Talk to an analyst

APO RESEARCH · REPORT

Scopolamine Butylbromide

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Scopolamine Butylbromide Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

20 December 2025190 pages

Choose your research edition.

Industry ResearchScopolamine Butylbromide Industry Research Report 2026134 pages · $2,950 USDIndustry Growth & TrendsGlobal Scopolamine Butylbromide Industry Growth and Trends Forecast to 2032116 pages · $3,450 USDMarket StructureGlobal Scopolamine Butylbromide Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Scopolamine Butylbromide Market Outlook and Growth Opportunities 2026204 pages · $4,250 USDMarket Analysis & ForecastGlobal Scopolamine Butylbromide Market Analysis and Forecast 2026-2032202 pages · $4,950 USD

Market perspective

The global Scopolamine Butylbromide market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Scopolamine Butylbromide is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Scopolamine Butylbromide is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Scopolamine Butylbromide is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Scopolamine Butylbromide is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Scopolamine Butylbromide include Abbott Laboratories, AdvaCare Pharma, AS Kalceks, AUSMED, Boehringer Ingelheim, Medsurge Healthcare, Pharma Cure Laboratories, Chengdu First Pharmaceutical and Jiangsu Hengrui Medicine, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Scopolamine Butylbromide market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Scopolamine Butylbromide and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Scopolamine Butylbromide sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Scopolamine Butylbromide market size, projected growth trends, production technologies, key applications, and end-use industries.

Scopolamine Butylbromide Segment by Company

Abbott Laboratories

AdvaCare Pharma

AS Kalceks

AUSMED

Boehringer Ingelheim

Medsurge Healthcare

Pharma Cure Laboratories

Chengdu First Pharmaceutical

Jiangsu Hengrui Medicine

North China Pharmaceutical Group

Qilu Pharmaceutical

Sanofi

Shanghai Shangyao First Bio-pharmaceutical

Sichuan Medco Huakang Pharmaceutical

Wepon

Yabao Pharmaceutical Group

Scopolamine Butylbromide Segment by Type

1ml:20mg

2ml:40mg

Scopolamine Butylbromide Segment by Application

Biliary Tract Spasm

Urinary Tract Spasm

Gastrointestinal Spasm

Scopolamine Butylbromide Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Scopolamine Butylbromide market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Scopolamine Butylbromide and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Scopolamine Butylbromide.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Scopolamine Butylbromide market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Scopolamine Butylbromide manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Scopolamine Butylbromide in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Scopolamine Butylbromide in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Scopolamine Butylbromide Industry Trends Table 2. Scopolamine Butylbromide Industry Drivers Table 3. Scopolamine Butylbromide Industry Opportunities and Challenges Table 4. Scopolamine Butylbromide Industry Restraints Table 5. Global Scopolamine Butylbromide Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Scopolamine Butylbromide Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Scopolamine Butylbromide Sales by Manufacturers (L) & (2021-2026) Table 8. Global Scopolamine Butylbromide Sales Market Share by Manufacturers Table 9. Global Scopolamine Butylbromide Average Sales Price (US$/ml) of Manufacturers (2021-2026) Table 10. Global Scopolamine Butylbromide Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Scopolamine Butylbromide Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Scopolamine Butylbromide Manufacturers, Product Type & Application Table 13. Global Scopolamine Butylbromide Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Scopolamine Butylbromide by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of 1ml:20mg Table 17. Major Manufacturers of 2ml:40mg Table 18. Global Scopolamine Butylbromide Sales by Type 2021 VS 2025 VS 2032 (L) Table 19. Global Scopolamine Butylbromide Sales by Type (2021-2026) & (L) Table 20. Global Scopolamine Butylbromide Sales by Type (2027-2032) & (L) Table 21. Global Scopolamine Butylbromide Sales Market Share by Type (2021-2026) Table 22. Global Scopolamine Butylbromide Sales Market Share by Type (2027-2032) Table 23. Global Scopolamine Butylbromide Revenue by Type 2021 VS 2025 VS 2032 (L) Table 24. Global Scopolamine Butylbromide Revenue by Type (2021-2026) & (L) Table 25. Global Scopolamine Butylbromide Revenue by Type (2027-2032) & (L) Table 26. Global Scopolamine Butylbromide Revenue Market Share by Type (2021-2026) Table 27. Global Scopolamine Butylbromide Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Biliary Tract Spasm Table 29. Major Manufacturers of Urinary Tract Spasm Table 30. Major Manufacturers of Gastrointestinal Spasm Table 31. Global Scopolamine Butylbromide Sales by Application 2021 VS 2025 VS 2032 (L) Table 32. Global Scopolamine Butylbromide Sales by Application (2021-2026) & (L) Table 33. Global Scopolamine Butylbromide Sales by Application (2027-2032) & (L) Table 34. Global Scopolamine Butylbromide Sales Market Share by Application (2021-2026) Table 35. Global Scopolamine Butylbromide Sales Market Share by Application (2027-2032) Table 36. Global Scopolamine Butylbromide Revenue by Application 2021 VS 2025 VS 2032 (L) Table 37. Global Scopolamine Butylbromide Revenue by Application (2021-2026) & (L) Table 38. Global Scopolamine Butylbromide Revenue by Application (2027-2032) & (L) Table 39. Global Scopolamine Butylbromide Revenue Market Share by Application (2021-2026) Table 40. Global Scopolamine Butylbromide Revenue Market Share by Application (2027-2032) Table 41. Global Scopolamine Butylbromide Sales by Region: 2021 VS 2025 VS 2032 (L) Table 42. Global Scopolamine Butylbromide Sales by Region (2021-2026) & (L) Table 43. Global Scopolamine Butylbromide Sales Market Share by Region (2021-2026) Table 44. Global Scopolamine Butylbromide Sales Forecasted by Region (2027-2032) & (L) Table 45. Global Scopolamine Butylbromide Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Scopolamine Butylbromide Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (L) Table 47. North America Scopolamine Butylbromide Sales by Country (2021-2026) & (L) Table 48. North America Scopolamine Butylbromide Sales by Country (2027-2032) & (L) Table 49. Europe Scopolamine Butylbromide Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (L) Table 50. Europe Scopolamine Butylbromide Sales by Country (2021-2026) & (L) Table 51. Europe Scopolamine Butylbromide Sales by Country (2027-2032) & (L) Table 52. Asia Pacific Scopolamine Butylbromide Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (L) Table 53. Asia Pacific Scopolamine Butylbromide Sales by Country (2021-2026) & (L) Table 54. Asia Pacific Scopolamine Butylbromide Sales by Country (2027-2032) & (L) Table 55. South America, Middle East and Africa Scopolamine Butylbromide Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (L) Table 56. South America, Middle East and Africa Scopolamine Butylbromide Sales by Country (2021-2026) & (L) Table 57. South America, Middle East and Africa Scopolamine Butylbromide Sales by Country (2027-2032) & (L) Table 58. Global Scopolamine Butylbromide Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Scopolamine Butylbromide Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Scopolamine Butylbromide Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Scopolamine Butylbromide Revenue Market Share by Region (2021-2026) Table 62. Global Scopolamine Butylbromide Revenue Market Share by Region (2027-2032) Table 63. Abbott Laboratories Company Information Table 64. Abbott Laboratories Business Overview Table 65. Abbott Laboratories Scopolamine Butylbromide Sales (L), Price (US$/ml), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Abbott Laboratories Scopolamine Butylbromide Product Portfolio Table 67. Abbott Laboratories Recent Development Table 68. AdvaCare Pharma Company Information Table 69. AdvaCare Pharma Business Overview Table 70. AdvaCare Pharma Scopolamine Butylbromide Sales (L), Price (US$/ml), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. AdvaCare Pharma Scopolamine Butylbromide Product Portfolio Table 72. AdvaCare Pharma Recent Development Table 73. AS Kalceks Company Information Table 74. AS Kalceks Business Overview Table 75. AS Kalceks Scopolamine Butylbromide Sales (L), Price (US$/ml), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. AS Kalceks Scopolamine Butylbromide Product Portfolio Table 77. AS Kalceks Recent Development Table 78. AUSMED Company Information Table 79. AUSMED Business Overview Table 80. AUSMED Scopolamine Butylbromide Sales (L), Price (US$/ml), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. AUSMED Scopolamine Butylbromide Product Portfolio Table 82. AUSMED Recent Development Table 83. Boehringer Ingelheim Company Information Table 84. Boehringer Ingelheim Business Overview Table 85. Boehringer Ingelheim Scopolamine Butylbromide Sales (L), Price (US$/ml), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Boehringer Ingelheim Scopolamine Butylbromide Product Portfolio Table 87. Boehringer Ingelheim Recent Development Table 88. Medsurge Healthcare Company Information Table 89. Medsurge Healthcare Business Overview Table 90. Medsurge Healthcare Scopolamine Butylbromide Sales (L), Price (US$/ml), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Medsurge Healthcare Scopolamine Butylbromide Product Portfolio Table 92. Medsurge Healthcare Recent Development Table 93. Pharma Cure Laboratories Company Information Table 94. Pharma Cure Laboratories Business Overview Table 95. Pharma Cure Laboratories Scopolamine Butylbromide Sales (L), Price (US$/ml), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Pharma Cure Laboratories Scopolamine Butylbromide Product Portfolio Table 97. Pharma Cure Laboratories Recent Development Table 98. Chengdu First Pharmaceutical Company Information Table 99. Chengdu First Pharmaceutical Business Overview Table 100. Chengdu First Pharmaceutical Scopolamine Butylbromide Sales (L), Price (US$/ml), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. Chengdu First Pharmaceutical Scopolamine Butylbromide Product Portfolio Table 102. Chengdu First Pharmaceutical Recent Development Table 103. Jiangsu Hengrui Medicine Company Information Table 104. Jiangsu Hengrui Medicine Business Overview Table 105. Jiangsu Hengrui Medicine Scopolamine Butylbromide Sales (L), Price (US$/ml), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. Jiangsu Hengrui Medicine Scopolamine Butylbromide Product Portfolio Table 107. Jiangsu Hengrui Medicine Recent Development Table 108. North China Pharmaceutical Group Company Information Table 109. North China Pharmaceutical Group Business Overview Table 110. North China Pharmaceutical Group Scopolamine Butylbromide Sales (L), Price (US$/ml), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. North China Pharmaceutical Group Scopolamine Butylbromide Product Portfolio Table 112. North China Pharmaceutical Group Recent Development Table 113. Qilu Pharmaceutical Company Information Table 114. Qilu Pharmaceutical Business Overview Table 115. Qilu Pharmaceutical Scopolamine Butylbromide Sales (L), Price (US$/ml), Revenue (US$ Million) and Gross Margin (2021-2026) Table 116. Qilu Pharmaceutical Scopolamine Butylbromide Product Portfolio Table 117. Qilu Pharmaceutical Recent Development Table 118. Sanofi Company Information Table 119. Sanofi Business Overview Table 120. Sanofi Scopolamine Butylbromide Sales (L), Price (US$/ml), Revenue (US$ Million) and Gross Margin (2021-2026) Table 121. Sanofi Scopolamine Butylbromide Product Portfolio Table 122. Sanofi Recent Development Table 123. Shanghai Shangyao First Bio-pharmaceutical Company Information Table 124. Shanghai Shangyao First Bio-pharmaceutical Business Overview Table 125. Shanghai Shangyao First Bio-pharmaceutical Scopolamine Butylbromide Sales (L), Price (US$/ml), Revenue (US$ Million) and Gross Margin (2021-2026) Table 126. Shanghai Shangyao First Bio-pharmaceutical Scopolamine Butylbromide Product Portfolio Table 127. Shanghai Shangyao First Bio-pharmaceutical Recent Development Table 128. Sichuan Medco Huakang Pharmaceutical Company Information Table 129. Sichuan Medco Huakang Pharmaceutical Business Overview Table 130. Sichuan Medco Huakang Pharmaceutical Scopolamine Butylbromide Sales (L), Price (US$/ml), Revenue (US$ Million) and Gross Margin (2021-2026) Table 131. Sichuan Medco Huakang Pharmaceutical Scopolamine Butylbromide Product Portfolio Table 132. Sichuan Medco Huakang Pharmaceutical Recent Development Table 133. Wepon Company Information Table 134. Wepon Business Overview Table 135. Wepon Scopolamine Butylbromide Sales (L), Price (US$/ml), Revenue (US$ Million) and Gross Margin (2021-2026) Table 136. Wepon Scopolamine Butylbromide Product Portfolio Table 137. Wepon Recent Development Table 138. Yabao Pharmaceutical Group Company Information Table 139. Yabao Pharmaceutical Group Business Overview Table 140. Yabao Pharmaceutical Group Scopolamine Butylbromide Sales (L), Price (US$/ml), Revenue (US$ Million) and Gross Margin (2021-2026) Table 141. Yabao Pharmaceutical Group Scopolamine Butylbromide Product Portfolio Table 142. Yabao Pharmaceutical Group Recent Development Table 143. Key Raw Materials Table 144. Raw Materials Key Suppliers Table 145. Scopolamine Butylbromide Distributors List Table 146. Scopolamine Butylbromide Customers List Table 147. Research Programs/Design for This Report Table 148. Authors List of This Report Table 149. Secondary Sources Table 150. Primary Sources List of Figures Figure 1. Scopolamine Butylbromide Product Image Figure 2. Global Scopolamine Butylbromide Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Scopolamine Butylbromide Market Size (2021-2032) & (US$ Million) Figure 4. Global Scopolamine Butylbromide Sales (2021-2032) & (L) Figure 5. Global Scopolamine Butylbromide Average Price (US$/ml) & (2021-2032) Figure 6. Global Top 5 and 10 Scopolamine Butylbromide Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. 1ml:20mg Image Figure 9. 2ml:40mg Image Figure 10. Global Scopolamine Butylbromide Sales by Type (2021 VS 2025 VS 2032) & (L) Figure 11. Global Scopolamine Butylbromide Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Scopolamine Butylbromide Sales Market Share by Type (2021-2032) Figure 13. Global Scopolamine Butylbromide Revenue by Type (2021 VS 2025 VS 2032) & (L) Figure 14. Global Scopolamine Butylbromide Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Scopolamine Butylbromide Revenue Market Share by Type (2021-2032) Figure 16. Biliary Tract Spasm Image Figure 17. Urinary Tract Spasm Image Figure 18. Gastrointestinal Spasm Image Figure 19. Global Scopolamine Butylbromide Sales by Application (2021 VS 2025 VS 2032) & (L) Figure 20. Global Scopolamine Butylbromide Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Scopolamine Butylbromide Sales Market Share by Application (2021-2032) Figure 22. Global Scopolamine Butylbromide Revenue by Application (2021 VS 2025 VS 2032) & (L) Figure 23. Global Scopolamine Butylbromide Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Scopolamine Butylbromide Revenue Market Share by Application (2021-2032) Figure 25. North America Scopolamine Butylbromide Sales and Growth Rate (2021-2032) & (L) Figure 26. North America Scopolamine Butylbromide Sales Market Share by Country (2021-2032) Figure 27. U.S. Scopolamine Butylbromide Sales and Growth Rate (2021-2032) & (L) Figure 28. Canada Scopolamine Butylbromide Sales and Growth Rate (2021-2032) & (L) Figure 29. Mexico Scopolamine Butylbromide Sales and Growth Rate (2021-2032) & (L) Figure 30. Europe Scopolamine Butylbromide Sales and Growth Rate (2021-2032) & (L) Figure 31. Europe Scopolamine Butylbromide Sales Market Share by Country (2021-2032) Figure 32. Germany Scopolamine Butylbromide Sales and Growth Rate (2021-2032) & (L) Figure 33. France Scopolamine Butylbromide Sales and Growth Rate (2021-2032) & (L) Figure 34. U.K. Scopolamine Butylbromide Sales and Growth Rate (2021-2032) & (L) Figure 35. Italy Scopolamine Butylbromide Sales and Growth Rate (2021-2032) & (L) Figure 36. Netherlands Scopolamine Butylbromide Sales and Growth Rate (2021-2032) & (L) Figure 37. Asia Pacific Scopolamine Butylbromide Sales and Growth Rate (2021-2032) & (L) Figure 38. Asia Pacific Scopolamine Butylbromide Sales Market Share by Country (2021-2032) Figure 39. China Scopolamine Butylbromide Sales and Growth Rate (2021-2032) & (L) Figure 40. Japan Scopolamine Butylbromide Sales and Growth Rate (2021-2032) & (L) Figure 41. South Korea Scopolamine Butylbromide Sales and Growth Rate (2021-2032) & (L) Figure 42. Southeast Asia Scopolamine Butylbromide Sales and Growth Rate (2021-2032) & (L) Figure 43. India Scopolamine Butylbromide Sales and Growth Rate (2021-2032) & (L) Figure 44. Australia Scopolamine Butylbromide Sales and Growth Rate (2021-2032) & (L) Figure 45. South America, Middle East and Africa Scopolamine Butylbromide Sales and Growth Rate (2021-2032) & (L) Figure 46. South America, Middle East and Africa Scopolamine Butylbromide Sales Market Share by Country (2021-2032) Figure 47. Brazil Scopolamine Butylbromide Sales and Growth Rate (2021-2032) & (L) Figure 48. South Africa Scopolamine Butylbromide Sales and Growth Rate (2021-2032) & (L) Figure 49. Saudi Arabia Scopolamine Butylbromide Sales and Growth Rate (2021-2032) & (L) Figure 50. Turkey Scopolamine Butylbromide Sales and Growth Rate (2021-2032) & (L) Figure 51. Argentina Scopolamine Butylbromide Sales and Growth Rate (2021-2032) & (L) Figure 52. UAE Scopolamine Butylbromide Sales and Growth Rate (2021-2032) & (L) Figure 53. Egypt Scopolamine Butylbromide Sales and Growth Rate (2021-2032) & (L) Figure 54. Chile Scopolamine Butylbromide Sales and Growth Rate (2021-2032) & (L) Figure 55. Global Scopolamine Butylbromide Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Scopolamine Butylbromide Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Scopolamine Butylbromide Revenue (2021-2032) & (US$ Million) Figure 58. North America Scopolamine Butylbromide Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Scopolamine Butylbromide Revenue (2021-2032) & (US$ Million) Figure 60. Europe Scopolamine Butylbromide Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Scopolamine Butylbromide Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Scopolamine Butylbromide Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Scopolamine Butylbromide Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Scopolamine Butylbromide Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Scopolamine Butylbromide Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Scopolamine Butylbromide Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • 1ml:20mg
  • 2ml:40mg
Applications
  • Biliary Tract Spasm
  • Urinary Tract Spasm
  • Gastrointestinal Spasm
Companies covered
  • Abbott Laboratories
  • AdvaCare Pharma
  • AS Kalceks
  • AUSMED
  • Boehringer Ingelheim
  • Medsurge Healthcare
  • Pharma Cure Laboratories
  • Chengdu First Pharmaceutical
  • Jiangsu Hengrui Medicine
  • North China Pharmaceutical Group
  • Qilu Pharmaceutical
  • Sanofi
  • Shanghai Shangyao First Bio-pharmaceutical
  • Sichuan Medco Huakang Pharmaceutical
  • Wepon
  • Yabao Pharmaceutical Group

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Scopolamine Butylbromide Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Scopolamine Butylbromide Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Scopolamine Butylbromide Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Scopolamine Butylbromide Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Scopolamine Butylbromide Market Dynamics
  1. 2.1 Scopolamine Butylbromide Industry Trends
  2. 2.2 Scopolamine Butylbromide Industry Drivers
  3. 2.3 Scopolamine Butylbromide Industry Opportunities and Challenges
  4. 2.4 Scopolamine Butylbromide Industry Restraints
3 Scopolamine Butylbromide Market by Manufacturers
  1. 3.1 Global Scopolamine Butylbromide Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Scopolamine Butylbromide Sales by Manufacturers (2021-2026)
  3. 3.3 Global Scopolamine Butylbromide Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Scopolamine Butylbromide Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Scopolamine Butylbromide Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Scopolamine Butylbromide Manufacturers, Product Type & Application
  7. 3.7 Global Scopolamine Butylbromide Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Scopolamine Butylbromide Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Scopolamine Butylbromide Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Scopolamine Butylbromide Tier 1, Tier 2, and Tier 3
4 Scopolamine Butylbromide Market by Type
  1. 4.1 Scopolamine Butylbromide Type Introduction
  2. 4.1.1 1ml:20mg
  3. 4.1.2 2ml:40mg
  4. 4.2 Global Scopolamine Butylbromide Sales by Type
  5. 4.2.1 Global Scopolamine Butylbromide Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Scopolamine Butylbromide Sales by Type (2021-2032)
  7. 4.2.3 Global Scopolamine Butylbromide Sales Market Share by Type (2021-2032)
  8. 4.3 Global Scopolamine Butylbromide Revenue by Type
  9. 4.3.1 Global Scopolamine Butylbromide Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Scopolamine Butylbromide Revenue by Type (2021-2032)
  11. 4.3.3 Global Scopolamine Butylbromide Revenue Market Share by Type (2021-2032)
5 Scopolamine Butylbromide Market by Application
  1. 5.1 Scopolamine Butylbromide Application Introduction
  2. 5.1.1 Biliary Tract Spasm
  3. 5.1.2 Urinary Tract Spasm
  4. 5.1.3 Gastrointestinal Spasm
  5. 5.2 Global Scopolamine Butylbromide Sales by Application
  6. 5.2.1 Global Scopolamine Butylbromide Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Scopolamine Butylbromide Sales by Application (2021-2032)
  8. 5.2.3 Global Scopolamine Butylbromide Sales Market Share by Application (2021-2032)
  9. 5.3 Global Scopolamine Butylbromide Revenue by Application
  10. 5.3.1 Global Scopolamine Butylbromide Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Scopolamine Butylbromide Revenue by Application (2021-2032)
  12. 5.3.3 Global Scopolamine Butylbromide Revenue Market Share by Application (2021-2032)
6 Global Scopolamine Butylbromide Sales by Region
  1. 6.1 Global Scopolamine Butylbromide Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Scopolamine Butylbromide Sales by Region (2021-2032)
  3. 6.2.1 Global Scopolamine Butylbromide Sales by Region (2021-2026)
  4. 6.2.2 Global Scopolamine Butylbromide Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Scopolamine Butylbromide Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Scopolamine Butylbromide Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Scopolamine Butylbromide Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Scopolamine Butylbromide Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Scopolamine Butylbromide Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Scopolamine Butylbromide Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Scopolamine Butylbromide Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Scopolamine Butylbromide Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Scopolamine Butylbromide Revenue by Region
  1. 7.1 Global Scopolamine Butylbromide Revenue by Region
  2. 7.1.1 Global Scopolamine Butylbromide Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Scopolamine Butylbromide Revenue by Region (2021-2026)
  4. 7.1.3 Global Scopolamine Butylbromide Revenue by Region (2027-2032)
  5. 7.1.4 Global Scopolamine Butylbromide Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Scopolamine Butylbromide Revenue (2021-2032)
  8. 7.2.2 North America Scopolamine Butylbromide Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Scopolamine Butylbromide Revenue (2021-2032)
  11. 7.3.2 Europe Scopolamine Butylbromide Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Scopolamine Butylbromide Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Scopolamine Butylbromide Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Scopolamine Butylbromide Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Scopolamine Butylbromide Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Abbott Laboratories
  2. 8.1.1 Abbott Laboratories Company Information
  3. 8.1.2 Abbott Laboratories Business Overview
  4. 8.1.3 Abbott Laboratories Scopolamine Butylbromide Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Abbott Laboratories Scopolamine Butylbromide Product Portfolio
  6. 8.1.5 Abbott Laboratories Recent Developments
  7. 8.2 AdvaCare Pharma
  8. 8.2.1 AdvaCare Pharma Company Information
  9. 8.2.2 AdvaCare Pharma Business Overview
  10. 8.2.3 AdvaCare Pharma Scopolamine Butylbromide Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 AdvaCare Pharma Scopolamine Butylbromide Product Portfolio
  12. 8.2.5 AdvaCare Pharma Recent Developments
  13. 8.3 AS Kalceks
  14. 8.3.1 AS Kalceks Company Information
  15. 8.3.2 AS Kalceks Business Overview
  16. 8.3.3 AS Kalceks Scopolamine Butylbromide Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 AS Kalceks Scopolamine Butylbromide Product Portfolio
  18. 8.3.5 AS Kalceks Recent Developments
  19. 8.4 AUSMED
  20. 8.4.1 AUSMED Company Information
  21. 8.4.2 AUSMED Business Overview
  22. 8.4.3 AUSMED Scopolamine Butylbromide Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 AUSMED Scopolamine Butylbromide Product Portfolio
  24. 8.4.5 AUSMED Recent Developments
  25. 8.5 Boehringer Ingelheim
  26. 8.5.1 Boehringer Ingelheim Company Information
  27. 8.5.2 Boehringer Ingelheim Business Overview
  28. 8.5.3 Boehringer Ingelheim Scopolamine Butylbromide Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Boehringer Ingelheim Scopolamine Butylbromide Product Portfolio
  30. 8.5.5 Boehringer Ingelheim Recent Developments
  31. 8.6 Medsurge Healthcare
  32. 8.6.1 Medsurge Healthcare Company Information
  33. 8.6.2 Medsurge Healthcare Business Overview
  34. 8.6.3 Medsurge Healthcare Scopolamine Butylbromide Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Medsurge Healthcare Scopolamine Butylbromide Product Portfolio
  36. 8.6.5 Medsurge Healthcare Recent Developments
  37. 8.7 Pharma Cure Laboratories
  38. 8.7.1 Pharma Cure Laboratories Company Information
  39. 8.7.2 Pharma Cure Laboratories Business Overview
  40. 8.7.3 Pharma Cure Laboratories Scopolamine Butylbromide Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Pharma Cure Laboratories Scopolamine Butylbromide Product Portfolio
  42. 8.7.5 Pharma Cure Laboratories Recent Developments
  43. 8.8 Chengdu First Pharmaceutical
  44. 8.8.1 Chengdu First Pharmaceutical Company Information
  45. 8.8.2 Chengdu First Pharmaceutical Business Overview
  46. 8.8.3 Chengdu First Pharmaceutical Scopolamine Butylbromide Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Chengdu First Pharmaceutical Scopolamine Butylbromide Product Portfolio
  48. 8.8.5 Chengdu First Pharmaceutical Recent Developments
  49. 8.9 Jiangsu Hengrui Medicine
  50. 8.9.1 Jiangsu Hengrui Medicine Company Information
  51. 8.9.2 Jiangsu Hengrui Medicine Business Overview
  52. 8.9.3 Jiangsu Hengrui Medicine Scopolamine Butylbromide Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Jiangsu Hengrui Medicine Scopolamine Butylbromide Product Portfolio
  54. 8.9.5 Jiangsu Hengrui Medicine Recent Developments
  55. 8.10 North China Pharmaceutical Group
  56. 8.10.1 North China Pharmaceutical Group Company Information
  57. 8.10.2 North China Pharmaceutical Group Business Overview
  58. 8.10.3 North China Pharmaceutical Group Scopolamine Butylbromide Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 North China Pharmaceutical Group Scopolamine Butylbromide Product Portfolio
  60. 8.10.5 North China Pharmaceutical Group Recent Developments
  61. 8.11 Qilu Pharmaceutical
  62. 8.11.1 Qilu Pharmaceutical Company Information
  63. 8.11.2 Qilu Pharmaceutical Business Overview
  64. 8.11.3 Qilu Pharmaceutical Scopolamine Butylbromide Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Qilu Pharmaceutical Scopolamine Butylbromide Product Portfolio
  66. 8.11.5 Qilu Pharmaceutical Recent Developments
  67. 8.12 Sanofi
  68. 8.12.1 Sanofi Company Information
  69. 8.12.2 Sanofi Business Overview
  70. 8.12.3 Sanofi Scopolamine Butylbromide Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Sanofi Scopolamine Butylbromide Product Portfolio
  72. 8.12.5 Sanofi Recent Developments
  73. 8.13 Shanghai Shangyao First Bio-pharmaceutical
  74. 8.13.1 Shanghai Shangyao First Bio-pharmaceutical Company Information
  75. 8.13.2 Shanghai Shangyao First Bio-pharmaceutical Business Overview
  76. 8.13.3 Shanghai Shangyao First Bio-pharmaceutical Scopolamine Butylbromide Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Shanghai Shangyao First Bio-pharmaceutical Scopolamine Butylbromide Product Portfolio
  78. 8.13.5 Shanghai Shangyao First Bio-pharmaceutical Recent Developments
  79. 8.14 Sichuan Medco Huakang Pharmaceutical
  80. 8.14.1 Sichuan Medco Huakang Pharmaceutical Company Information
  81. 8.14.2 Sichuan Medco Huakang Pharmaceutical Business Overview
  82. 8.14.3 Sichuan Medco Huakang Pharmaceutical Scopolamine Butylbromide Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Sichuan Medco Huakang Pharmaceutical Scopolamine Butylbromide Product Portfolio
  84. 8.14.5 Sichuan Medco Huakang Pharmaceutical Recent Developments
  85. 8.15 Wepon
  86. 8.15.1 Wepon Company Information
  87. 8.15.2 Wepon Business Overview
  88. 8.15.3 Wepon Scopolamine Butylbromide Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Wepon Scopolamine Butylbromide Product Portfolio
  90. 8.15.5 Wepon Recent Developments
  91. 8.16 Yabao Pharmaceutical Group
  92. 8.16.1 Yabao Pharmaceutical Group Company Information
  93. 8.16.2 Yabao Pharmaceutical Group Business Overview
  94. 8.16.3 Yabao Pharmaceutical Group Scopolamine Butylbromide Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Yabao Pharmaceutical Group Scopolamine Butylbromide Product Portfolio
  96. 8.16.5 Yabao Pharmaceutical Group Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Scopolamine Butylbromide Value Chain Analysis
  2. 9.1.1 Scopolamine Butylbromide Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Scopolamine Butylbromide Production Mode & Process
  6. 9.2 Scopolamine Butylbromide Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Scopolamine Butylbromide Distributors
  9. 9.2.3 Scopolamine Butylbromide Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst